484 related articles for article (PubMed ID: 26500000)
1. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
Petersen KS; Rushworth RL; Clifton PM; Torpy DJ
BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison's Disease).
Meyer G; Hackemann A; Reusch J; Badenhoop K
Diabetes Technol Ther; 2012 May; 14(5):386-8. PubMed ID: 22242902
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
4. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
Smans L; Lentjes E; Hermus A; Zelissen P
Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
[TBL] [Abstract][Full Text] [Related]
5. Replacement therapy in Addison's disease.
Løvås K; Husebye ES
Expert Opin Pharmacother; 2003 Dec; 4(12):2145-9. PubMed ID: 14640913
[TBL] [Abstract][Full Text] [Related]
6. Replacement therapy for Addison's disease: recent developments.
Løvås K; Husebye ES
Expert Opin Investig Drugs; 2008 Apr; 17(4):497-509. PubMed ID: 18363515
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].
Salah DB; Charfi N; Elleuch M; Kacem FH; Rekik N; Mnif M; Mnif F; Abid M
Pan Afr Med J; 2018; 30():251. PubMed ID: 30627312
[TBL] [Abstract][Full Text] [Related]
8. Addison's disease in pregnancy: Case report, management, and review of the literature.
Margulies SL; Corrigan K; Bathgate S; Macri C
J Neonatal Perinatal Med; 2020; 13(2):275-278. PubMed ID: 31744021
[TBL] [Abstract][Full Text] [Related]
9. Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.
Campean R; Hasun M; Stöllberger C; Bucher J; Finsterer J; Schnack C; Weidinger F
J Med Case Rep; 2016 Oct; 10(1):281. PubMed ID: 27729057
[TBL] [Abstract][Full Text] [Related]
10. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
[TBL] [Abstract][Full Text] [Related]
11. Subjective health status in Norwegian patients with Addison's disease.
Løvås K; Loge JH; Husebye ES
Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
[TBL] [Abstract][Full Text] [Related]
12. Current and emerging therapies for Addison's disease.
Napier C; Pearce SH
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
[TBL] [Abstract][Full Text] [Related]
13. Recurrent hypoglycaemia in type-1 diabetes mellitus may unravel the association with Addison's disease: a case report.
Passanisi S; Timpanaro T; Lo Presti D; Caruso-Nicoletti M
BMC Res Notes; 2014 Sep; 7():634. PubMed ID: 25214204
[TBL] [Abstract][Full Text] [Related]
14. Akinetic mutism followed by a manic reaction on introduction of steroid replacement for Addison's disease.
Kalambokis G; Konitsiotis S; Pappas D; Tsianos EV
J Endocrinol Invest; 2006 Mar; 29(3):257-60. PubMed ID: 16682841
[TBL] [Abstract][Full Text] [Related]
15. [Addison's disease : Primary adrenal insufficiency].
Pulzer A; Burger-Stritt S; Hahner S
Internist (Berl); 2016 May; 57(5):457-69. PubMed ID: 27129928
[TBL] [Abstract][Full Text] [Related]
16. Addison's disease associated with hypokalemia: a case report.
Abdalla M; Dave JA; Ross IL
J Med Case Rep; 2021 Mar; 15(1):131. PubMed ID: 33761983
[TBL] [Abstract][Full Text] [Related]
17. Screening for Addison's disease in patients with type 1 diabetes mellitus and recurrent hypoglycaemia.
Likhari T; Magzoub S; Griffiths MJ; Buch HN; Gama R
Postgrad Med J; 2007 Jun; 83(980):420-1. PubMed ID: 17551075
[TBL] [Abstract][Full Text] [Related]
18. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.
Berardelli R; Karamouzis I; D'Angelo V; Fussotto B; Minetto MA; Ghigo E; Giordano R; Arvat E
J Endocrinol Invest; 2016 May; 39(5):537-42. PubMed ID: 26450146
[TBL] [Abstract][Full Text] [Related]
19. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
[TBL] [Abstract][Full Text] [Related]
20. Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison's disease.
van der Valk ES; Smans LC; Hofstetter H; Stubbe JH; de Vries M; Backx FJ; Hermus AR; Zelissen PM
Clin Endocrinol (Oxf); 2016 Sep; 85(3):354-60. PubMed ID: 26953557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
